UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ACVR2A-AKT3 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ACVR2A-AKT3 | FusionPDB ID: 1904 | FusionGDB2.0 ID: 1904 | Hgene | Tgene | Gene symbol | ACVR2A | AKT3 | Gene ID | 92 | 10000 |
Gene name | activin A receptor type 2A | AKT serine/threonine kinase 3 | |
Synonyms | ACTRII|ACVR2 | MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2 | |
Cytomap | 2q22.3-q23.1 | 1q43-q44 | |
Type of gene | protein-coding | protein-coding | |
Description | activin receptor type-2Aactivin A receptor, type IIA | RAC-gamma serine/threonine-protein kinasePKB gammaRAC-gamma serine/threonine protein kinasev-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P27037 | Q9Y243 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000241416, ENST00000404590, ENST00000495775, ENST00000535787, | ENST00000492957, ENST00000263826, ENST00000336199, ENST00000366539, ENST00000366540, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 8 X 7 X 7=392 | 19 X 18 X 8=2736 |
# samples | 10 | 19 | |
** MAII score | log2(10/392*10)=-1.97085365434048 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(19/2736*10)=-3.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ACVR2A [Title/Abstract] AND AKT3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ACVR2A(148602776)-AKT3(243828185), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | ACVR2A-AKT3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACVR2A-AKT3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACVR2A-AKT3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ACVR2A-AKT3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ACVR2A | GO:0030509 | BMP signaling pathway | 18436533 |
Hgene | ACVR2A | GO:0032927 | positive regulation of activin receptor signaling pathway | 12665502 |
Hgene | ACVR2A | GO:0045648 | positive regulation of erythrocyte differentiation | 9032295 |
Tgene | AKT3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 28254819 |
Tgene | AKT3 | GO:1905564 | positive regulation of vascular endothelial cell proliferation | 28254819 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-G9-6348-01A | ACVR2A | chr2 | 148602776 | - | AKT3 | chr1 | 243828185 | - |
ChimerDB4 | PRAD | TCGA-G9-6348-01A | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - |
ChimerDB4 | PRAD | TCGA-G9-6348 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000241416 | ACVR2A | chr2 | 148602776 | + | ENST00000336199 | AKT3 | chr1 | 243828185 | - | 2141 | 691 | 636 | 1916 | 426 |
ENST00000241416 | ACVR2A | chr2 | 148602776 | + | ENST00000366540 | AKT3 | chr1 | 243828185 | - | 1941 | 691 | 636 | 1916 | 426 |
ENST00000241416 | ACVR2A | chr2 | 148602776 | + | ENST00000366539 | AKT3 | chr1 | 243828185 | - | 5445 | 691 | 636 | 1958 | 440 |
ENST00000241416 | ACVR2A | chr2 | 148602776 | + | ENST00000263826 | AKT3 | chr1 | 243828185 | - | 4026 | 691 | 636 | 1958 | 440 |
ENST00000404590 | ACVR2A | chr2 | 148602776 | + | ENST00000336199 | AKT3 | chr1 | 243828185 | - | 1675 | 225 | 170 | 1450 | 426 |
ENST00000404590 | ACVR2A | chr2 | 148602776 | + | ENST00000366540 | AKT3 | chr1 | 243828185 | - | 1475 | 225 | 170 | 1450 | 426 |
ENST00000404590 | ACVR2A | chr2 | 148602776 | + | ENST00000366539 | AKT3 | chr1 | 243828185 | - | 4979 | 225 | 170 | 1492 | 440 |
ENST00000404590 | ACVR2A | chr2 | 148602776 | + | ENST00000263826 | AKT3 | chr1 | 243828185 | - | 3560 | 225 | 170 | 1492 | 440 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000241416 | ENST00000336199 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000185123 | 0.9998149 |
ENST00000241416 | ENST00000366540 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000158602 | 0.99984133 |
ENST00000241416 | ENST00000366539 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000146314 | 0.9998536 |
ENST00000241416 | ENST00000263826 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000177255 | 0.9998228 |
ENST00000404590 | ENST00000336199 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000337805 | 0.99966216 |
ENST00000404590 | ENST00000366540 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000322046 | 0.999678 |
ENST00000404590 | ENST00000366539 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000198379 | 0.9998017 |
ENST00000404590 | ENST00000263826 | ACVR2A | chr2 | 148602776 | + | AKT3 | chr1 | 243828185 | - | 0.000272105 | 0.9997279 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >1904_1904_1_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000241416_AKT3_chr1_243828185_ENST00000263826_length(amino acids)=440AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_2_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000241416_AKT3_chr1_243828185_ENST00000336199_length(amino acids)=426AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_3_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000241416_AKT3_chr1_243828185_ENST00000366539_length(amino acids)=440AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_4_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000241416_AKT3_chr1_243828185_ENST00000366540_length(amino acids)=426AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_5_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000404590_AKT3_chr1_243828185_ENST00000263826_length(amino acids)=440AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_6_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000404590_AKT3_chr1_243828185_ENST00000336199_length(amino acids)=426AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_7_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000404590_AKT3_chr1_243828185_ENST00000366539_length(amino acids)=440AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- >1904_1904_8_ACVR2A-AKT3_ACVR2A_chr2_148602776_ENST00000404590_AKT3_chr1_243828185_ENST00000366540_length(amino acids)=426AA_BP=18 MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:148602776/chr1:243828185) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ACVR2A | AKT3 |
FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A. Mediates induction of adipogenesis by GDF6 (By similarity). {ECO:0000250|UniProtKB:P27038, ECO:0000269|PubMed:1314589}. | FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000263826 | 1 | 13 | 148_405 | 57.333333333333336 | 480.0 | Domain | Protein kinase | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000263826 | 1 | 13 | 406_479 | 57.333333333333336 | 480.0 | Domain | AGC-kinase C-terminal | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000336199 | 1 | 14 | 148_405 | 57.333333333333336 | 476.0 | Domain | Protein kinase | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000336199 | 1 | 14 | 406_479 | 57.333333333333336 | 476.0 | Domain | AGC-kinase C-terminal | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366539 | 2 | 14 | 148_405 | 57.333333333333336 | 480.0 | Domain | Protein kinase | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366539 | 2 | 14 | 406_479 | 57.333333333333336 | 480.0 | Domain | AGC-kinase C-terminal | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366540 | 2 | 14 | 148_405 | 57.333333333333336 | 466.0 | Domain | Protein kinase | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366540 | 2 | 14 | 406_479 | 57.333333333333336 | 466.0 | Domain | AGC-kinase C-terminal | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000263826 | 1 | 13 | 154_162 | 57.333333333333336 | 480.0 | Nucleotide binding | ATP | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000336199 | 1 | 14 | 154_162 | 57.333333333333336 | 476.0 | Nucleotide binding | ATP | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366539 | 2 | 14 | 154_162 | 57.333333333333336 | 480.0 | Nucleotide binding | ATP | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366540 | 2 | 14 | 154_162 | 57.333333333333336 | 466.0 | Nucleotide binding | ATP |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000241416 | + | 1 | 11 | 192_485 | 18.333333333333332 | 514.0 | Domain | Protein kinase |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000404590 | + | 2 | 12 | 192_485 | 18.333333333333332 | 514.0 | Domain | Protein kinase |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000241416 | + | 1 | 11 | 198_206 | 18.333333333333332 | 514.0 | Nucleotide binding | ATP |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000404590 | + | 2 | 12 | 198_206 | 18.333333333333332 | 514.0 | Nucleotide binding | ATP |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000241416 | + | 1 | 11 | 162_513 | 18.333333333333332 | 514.0 | Topological domain | Cytoplasmic |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000241416 | + | 1 | 11 | 20_135 | 18.333333333333332 | 514.0 | Topological domain | Extracellular |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000404590 | + | 2 | 12 | 162_513 | 18.333333333333332 | 514.0 | Topological domain | Cytoplasmic |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000404590 | + | 2 | 12 | 20_135 | 18.333333333333332 | 514.0 | Topological domain | Extracellular |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000241416 | + | 1 | 11 | 136_161 | 18.333333333333332 | 514.0 | Transmembrane | Helical |
Hgene | ACVR2A | chr2:148602776 | chr1:243828185 | ENST00000404590 | + | 2 | 12 | 136_161 | 18.333333333333332 | 514.0 | Transmembrane | Helical |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000263826 | 1 | 13 | 5_107 | 57.333333333333336 | 480.0 | Domain | PH | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000336199 | 1 | 14 | 5_107 | 57.333333333333336 | 476.0 | Domain | PH | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366539 | 2 | 14 | 5_107 | 57.333333333333336 | 480.0 | Domain | PH | |
Tgene | AKT3 | chr2:148602776 | chr1:243828185 | ENST00000366540 | 2 | 14 | 5_107 | 57.333333333333336 | 466.0 | Domain | PH |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>922_ACVR2A_148602776_AKT3_243828185_922_ACVR2A_148602776_AKT3_243828185_ranked_0.pdb | ACVR2A | 148602776 | 148602776 | ENST00000263826 | AKT3 | chr1 | 243828185 | - | MGAAAKLAFAVFLISCSSECQLMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCSPTSQIDNIG EEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEI | 440 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
ACVR2A_pLDDT.png![]() |
AKT3_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ACVR2A | |
AKT3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ACVR2A-AKT3 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ACVR2A-AKT3 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |